SCHEMBL13047469

SCHEMBL13047469

Cc1ccc(C)c(C(=O)Nc2cccc3c(=O)n(C)ccc23)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.46
GAA P10253 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
PARP1 P09874 2/20 0.46
TP53 P04637 2/20 0.45
MAPT P10636 2/20 0.45
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 3/20 0.42
TSHR P16473 1/20 0.42
RAB9A P51151 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
BRD4 O60885 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13047468 0.86 PARP1 (0.60) PARP1TP53KDM4ELMNATSHR
SCHEMBL13047503 0.84 RXFP1 (0.55) POLBTP53MAPTKDM4ELMNA
SCHEMBL13047142 0.83 PARP1 (0.50) POLBPARP1TP53MAPTKDM4E
SCHEMBL13046842 0.83 POLB (0.48) POLBPARP1TP53LMNASMN1; SMN2
SCHEMBL13047447 0.82 POLB (0.45) POLBPARP1TP53MAPTKMT2A
SCHEMBL1590428 0.82 P2RX7 (0.54) POLBPARP1TP53MAPTKMT2A
SCHEMBL1590529 0.82 POLB (0.44) POLBPARP1TP53MAPTKMT2A
SCHEMBL1590922 0.82 POLB (0.44) POLBPARP1TP53MAPTKMT2A
SCHEMBL13046927 0.80 POLB (0.45) POLBTP53MAPTKMT2AKDM4E
SCHEMBL13587425 0.79 KDM4E (0.41) POLBGAAPARP1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546579-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof EVOTEC (US) INC. (US) 2013-10-01 US disclosed
US-8546579-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof EVOTEC (US) INC. (US) 2013-10-01 US disclosed
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof SECOND GENOME, INC. 2010-11-18 US disclosed
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof SECOND GENOME, INC. 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 POLB 3676/4885GAA 4179/4885TDP1 2440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.